Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $13.7100 (1.33%) ($13.7100 - $13.7100) on Mon. Oct. 17, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.85% (three month average) | RSI | 67 | Latest Price | $13.7100(1.33%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | BCRX advances 3.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XLK(28%) URA(27%) VUG(27%) VT(26%) BLOK(25%) | Factors Impacting BCRX price | BCRX will decline at least -1.925% in a week (0% probabilities). SMH(-16%) VIXM(-12%) UUP(-8%) EDOC(-7%) VXX(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.925% (StdDev 3.85%) | Hourly BBV | -0.8 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $13.75(-0.29%) | 10 Day Moving Average | $13.85(-1.01%) | 20 Day Moving Average | $13.3(3.08%) | To recent high | -7.5% | To recent low | 27.2% | Market Cap | $2.419b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |